KEWAUNEE SCIENTIFIC CORPKEQU決算レポート
Kewaunee Scientific Corporation designs, manufactures, and installs specialized laboratory furniture, fume hoods, and integrated laboratory infrastructure solutions. It serves clients across pharmaceutical, biotech, academic research, healthcare, and industrial R&D segments, with core operations in North America and a steadily expanding global customer base.
What changed in KEWAUNEE SCIENTIFIC CORP's 10-K — 2024 vs 2025
Top changes in KEWAUNEE SCIENTIFIC CORP's 2025 10-K
162 paragraphs added · 114 removed · 92 edited across 8 sections
- Item 7. Management's Discussion & Analysis+55 / −47 · 32 edited
- Item 1A. Risk Factors+62 / −32 · 28 edited
- Item 1. Business+31 / −22 · 20 edited
- Item 7A. Quantitative and Qualitative Disclosures About Market Risk+7 / −6 · 5 edited
- Item 2. Properties+3 / −3 · 3 edited
Item 1. Business
Business — how the company describes what it does
20 edited+11 added−2 removed5 unchanged
Item 1. Business
Business — how the company describes what it does
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
28 edited+34 added−4 removed58 unchanged
Item 1A. Risk Factors
Risk Factors — what could go wrong, per management
Item 1C. Cybersecurity
Cybersecurity — threats and controls disclosure
1 edited+0 added−0 removed10 unchanged
Item 1C. Cybersecurity
Cybersecurity — threats and controls disclosure
Item 2. Properties
Properties — owned and leased real estate
3 edited+0 added−0 removed1 unchanged
Item 2. Properties
Properties — owned and leased real estate
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
1 edited+0 added−0 removed1 unchanged
Item 3. Legal Proceedings
Legal Proceedings — active lawsuits and investigations
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
2 edited+0 added−0 removed2 unchanged
Item 5. Market for Registrant's Common Equity
Market for Common Equity — stock, dividends, buybacks
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
32 edited+23 added−15 removed4 unchanged
Item 7. Management's Discussion & Analysis
Management's Discussion & Analysis (MD&A) — revenue / margin commentary
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure
5 edited+2 added−1 removed1 unchanged
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
Market Risk — interest-rate, FX, commodity exposure